Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AZ and The Medicines Co. ally again, now to co-promote Brilinta

Executive Summary

AstraZeneca PLC and The Medicines Co. (TMC) have joined forces again, this time to co-promote AZ’s oral antiplatelet drug Brilinta (ticagrelor), and potentially work together on other acute ischemic heart disease therapies.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • R&D and Marketing (Licensing)
    • Reverse Licensing

Related Companies